ULTOMIRIS

Concentrate for solution for infusion, 1100mg/11ml
RxActive license

Active substance (INN)

ravulizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength1100mg/11ml
PackagingUkupno 1 bočica staklena sa 11ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAlexion Pharma International Operations Limited, Ireland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AJ02)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateSeptember 27, 2022

Analogs in Montenegro

1

Other medicines with the same active substance

ULTOMIRISRx
Concentrate for solution for infusion, 300mg/3mlAlexion Pharma International Operations Limited
Source: CInMED register